Legal Opinion

Axcan Scandipharm Inc. v. Ethex Corp.

District Court, D. Minnesota

Decided October 19, 2007No. 07-2556 (RHK/JSM)PublishedCited by 14 opinions

1Opinion of the Court

MEMORANDUM OPINION AND ORDER

RICHARD H. KYLE, United States District Judge.

INTRODUCTION

The Plaintiff in this Lanham-Act action, Axcan Scandipharm, Inc. (“Axcan”), manufactures and markets the “Ultrase” line of panereatie-enzyme-supplement drugs. Defendants Ethex Corporation (“Ethex”) and KV Pharmaceutical Company (“KV”) manufacture and sell a “generic” line of Ultrase called “Pangestyme.” Similarly, Defendants Impax Laboratories, Inc. (“Impax”) and Global Pharmaceuticals (“Global”) manufacture and sell a different “generic” line of Ultrase called “Lipram.” In this action, Axcan alleges that…

2Cases cited41 opinions

  1. Bell Atlantic Corp. v. TwomblySupreme Court of the United States · 2007
  2. National Railroad Passenger Corporation v. MorganSupreme Court of the United States · 2002
  3. Bell v. HoodSupreme Court of the United States · 1946
  4. Lawrence H. Ramming v. United States of America, John Thomas Cloud v. United StatesCourt of Appeals for the Fifth Circuit · 2001
  5. Vicki Westcott, Administratrix of the Estate of Arden Westcott, Deceased v. City of Omaha, a Municipal CorporationCourt of Appeals for the Eighth Circuit · 1990

36 more not listed; retrieve them via the Exa API.

3Cited by14 opinions

  1. United States v. City of Loveland, OhioCourt of Appeals for the Sixth Circuit · 2010
  2. Podpeskar v. Makita U.S.A. Inc.District Court, D. Minnesota · 2017
  3. Rexall Sundown, Inc. v. Perrigo Co.District Court, E.D. New York · 2009
  4. In re Polaris Mktg.District Court, D. Maine · 2019
  5. Mission Pharmacal Co. v. Virtus Pharmaceuticals, LLCDistrict Court, W.D. Texas · 2014

9 more not listed; retrieve them via the Exa API.

Showing a preview — retrieve the full document via the Exa API.

Powered by the Exa API